Thyroglossal cysts in a pediatric population: apparent differences from adult thyroglossal cysts

Puthen Veetil Pradeep1, Buruju Jayashree

  • 1Endocrine Surgery, Narayana Medical College, Andhra Pradesh, India. pradeepputhenveetil@yahoo.co.in

Insights

Thyroglossal duct cysts (TGDC) present differently in children and adults. The Sistrunk procedure effectively treats TGDC in both pediatric and adult populations with no recurrence.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Surgical Pathology

Background:

  • Thyroglossal duct cysts (TGDC) are congenital anomalies with variable clinical presentations.
  • Limited studies compare the clinical characteristics and management of TGDC between pediatric and adult patients.

Purpose of the Study:

  • To investigate variations in the clinical presentation of TGDC between children and adults.
  • To determine if observed differences impact optimal management strategies.

Main Methods:

  • Retrospective analysis of 46 patients operated on for TGDC between February 2008 and November 2011.
  • Comparison of demographic data, clinical presentation, imaging, surgical management, complications, and recurrence rates between pediatric (<18 years) and adult patients.

Main Results:

  • Pediatric TGDC cases showed a higher prevalence of hypothyroidism (56.3% vs. 6.7%) and a shorter duration of disease.
  • Adults presented more frequently with infected TGDC or fistulae (20% vs. 0%).
  • Male children had larger cysts than female children; the Sistrunk procedure yielded excellent outcomes in all patients.

Conclusions:

  • TGDC exhibits distinct clinical features in pediatric versus adult populations.
  • Hypothyroidism is significantly more common in pediatric TGDC.
  • The Sistrunk procedure is a safe and effective treatment for TGDC in both age groups.
Abstract

Related Concept Videos

Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...